Ph.D. Sir Marc Feldmann - 28 Dec 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Sir Marc Feldmann, Ph.D.
Issuer symbol
ATNF
Transactions as of
28 Dec 2023
Net transactions value
$0
Form type
4
Filing time
28 Dec 2023, 18:42:49 UTC
Previous filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $0 +135,377 +117% $0.000000 250,874 28 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.